A study called Effisayil 2 found that spesolimab was helpful in preventing flare-ups of generalized pustular psoriasis.

Published Date: 07 Jul 2023

USA: New late-breaking data from the Effisayil 2 trial showed an 84 percent reduction in the risk for flare-ups of generalized pustular psoriasis (GPP).

Read Full News

Latest News

HPV Vaccination Underutilized in Transplant Recipients

HPV vaccination rates were low among solid organ transplant recipients, a study shows.

Navigating GLP-1 Hair Loss With Your Patients

Patients are increasingly anxious about hair shedding on GLP-1s. Here is what the latest research shows, why it happens, and how to manage it in the clinic.

Self-Detection, Male Sex Linked to Thicker Melanomas

Detection patterns, reasons for consultation, and sex-based differences strongly influence tumour thickness and prognosis in young adults with cutaneous melanoma, a retrospective study finds.

France Reports New Local Arboviral Infections in 2026

Imported arboviral infections are climbing in France, with locally acquired cases now reported. Clinicians are urged to spot early clues and report suspected cases fast.

What to Tell Patients Worried About PFAS Exposure

PFAS exposure is widespread, but clinicians can help patients understand the main sources, potential health effects, and practical ways to reduce risk.

Cherry Angiomas Linked to Neurofibromatosis Type 1

People with neurofibromatosis type 1 often have cherry angiomas, an unrecognized vascular manifestation of NF1, a study indicates.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Latest News

HPV vaccination rates were low among solid organ transplant recipients, a study shows.

Patients are increasingly anxious about hair shedding on GLP-1s. Here is what the latest research shows, why it happens, and how to manage it in the clinic.

Detection patterns, reasons for consultation, and sex-based differences strongly influence tumour thickness and prognosis in young adults with cutaneous melanoma, a retrospective study finds.

Imported arboviral infections are climbing in France, with locally acquired cases now reported. Clinicians are urged to spot early clues and report suspected cases fast.

PFAS exposure is widespread, but clinicians can help patients understand the main sources, potential health effects, and practical ways to reduce risk.

People with neurofibromatosis type 1 often have cherry angiomas, an unrecognized vascular manifestation of NF1, a study indicates.

News All Time

Can Apremilast Curb PsA in Patients With Psoriasis?

A 24-week course of the phosphodiesterase 4 inhibitor apremilast may ease skin symptoms and joint tenderness while keeping early bone changes stable in high-risk patients with psoriasis.

WHO Defends Immunisation Schedules After Trump Orders Fewer Childhood Shots

The World Health Organization on Tuesday defended the science-based process used to determine childhood immunisation schedules after U.S. President Donald Trump signed an...

Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib

In the wake of striking survival data, more than 2000 US patients are receiving daraxonrasib before FDA approval.

Trump Order Reduces US Vaccine Schedule, Seeks to Split MMR Shot

U.S. President Donald Trump signed an executive order on Monday calling for fewer childhood vaccinations by limiting the inoculation schedule to 11 immunizations, which he...

Alopecia in Transgender Patients: Management Strategies

Low-dose oral minoxidil ranks high as a first-line alopecia treatment option for transmasculine individuals and, especially in combination with spironolactone, for transfeminine patients.

Wellness Peptides Are Trending: Are They Safe?

Growing interest in unapproved peptides is raising concerns about weak human evidence, uncertain product quality, self-administration, and poorly understood long-term safety.

Skin Cancer Prevention Gaps Seen in Indigenous Adults

A survey of American Indian/Alaska Native adults in South Dakota finds low sunscreen use and gaps in skin cancer risk perception and knowledge.

Hemangiomas: Absence of One Feature May Rule Out Syndrome

A systematic review of patients with LUMBAR syndrome found that the anatomic midline was involved in all cases, raising the possibility that this is a diagnostic criterion.

Hyperinsulinemic Hypoglycemia: Looking Beyond Insulinoma?

A distinctive metabolic signature may identify rare insulin receptor disorders earlier, helping clinicians avoid unnecessary insulinoma investigations.

FDA Approves Replimune Skin Cancer Drug After Rejections

The accelerated approval follows FDA concerns about the single-arm evidence supporting the treatment.

TikTok Turns Isotretinoin Into a Beauty Trend

Social media has fueled new demand for isotretinoin, but the drug’s true value and its best-known risks remain defined by evidence, not influencer hype.

Manufacturer Files for Botox Approval for Jawline Contouring

After positive findings from phase 3 trials, Allergan Aesthetics submits sBLA to the FDA for onabotulinumtoxinA, to improve the appearance of the masseter muscle.

Combo Therapy May Clear Stubborn Warts Faster

Combining topical urea with carboxytherapy may help reduce lesion size more effectively and achieve faster clearance than urea alone in patients with treatment-resistant common warts.

Deucravacitinib Shows Sustained Efficacy and Safety in PsA

Deucravacitinib shows greater efficacy than placebo in adults with active psoriatic arthritis at week 16, with sustained benefits through week 52 and a well-tolerated safety profile.

CSCC Incidence, NMSC Mortality Rise in England

The incidence of keratinocyte cancer rose in England from 2013 to 2022, with a stabilising incidence of BCC, an increasing incidence of cutaneous squamous cell carcinoma, and rising NMSC mortality.

Surgeons Warn of 'Regulatory Gap' in Cosmetic Surgery

Surgical royal colleges warn the government's delayed consultation leaves patients exposed to under-qualified practitioners.

Recommended News For You

Is Laughter Good for Blood Glucose Control?

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

Glioblastoma treatment breakthrough shows promise

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Recommended Articles For You

The Latest Advances in Glioblastoma Treatment and Prevention  

A Closer Look at MCV Modules: Features, Functions, and Benefits  

The importance of understanding normal serum osmolality 

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

3.

Taking vitamin D daily decreased cancer mortality, according to a study.

4.

Study reveals increase in late-stage breast cancer diagnoses in US

5.

Prostate cancer Q&A: Improving detection and reducing overtreatment

1.

Virtual Survivorship Platforms in Cancer Care: Transforming Post-Treatment Support and Outcomes

2.

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment

3.

Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025

4.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

5.

Women's Cancer Survivorship: Emerging Long-Term Health Priorities

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

3.

Expert Perspectives on Hematology

4.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

5.

Navigating the Complexities of Ph Negative ALL - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot